Inventor · disambiguated record
Mark Mcdonnell
Also filed as: MCDONNELL MARK · MCDONNELL MARK E
36 granted patents·9 pending applications·392 citations·filing 1999–2025
97Inventor score
Files withJANSSEN PHARMACEUTICA NV10WISTAR INST8BIAN HAIYAN5BIOHAVEN PHARM HOLDING CO LTD5OLIGOMERIX INC5
Top patents by PatentIndex Score
45 records- 0198US8426401B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Apr 23, 2013·77 cites·18 claims
- 0297US8741887B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jun 3, 2014·49 cites·4 claims
- 0397US8697684B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·48 cites·4 claims
- 0497US8604017B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Dec 10, 2013·49 cites·4 claims
- 0597US8399454B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Mar 19, 2013·53 cites·17 claims
- 0695US9725427B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2013·Granted Aug 8, 2017·20 cites·11 claims
- 0792US11440893B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Sep 13, 2022·2 cites·5 claims
- 0892US11242317B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2019·Granted Feb 8, 2022·4 cites·17 claims
- 0991US10981867B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2019·Granted Apr 20, 2021·3 cites·13 claims
- 1091US10442763B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2016·Granted Oct 15, 2019·4 cites·5 claims
- 1190US10844026B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Nov 24, 2020·2 cites·7 claims
- 1290US8367653B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Feb 5, 2013·8 cites·19 claims
- 1388US10562870B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Feb 18, 2020·2 cites·3 claims
- 1486US8455476B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Jun 4, 2013·5 cites·30 claims
- 1586US8415341B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsCHEVALIER KRISTEN·Filed 2010·Granted Apr 9, 2013·18 cites·18 claims
- 1685US8513423B2Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Aug 20, 2013·8 cites·16 claims
- 1785US8362001B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·4 cites·18 claims
- 1884US8445477B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 21, 2013·4 cites·20 claims
- 1984US2024246909A1EBNA1 Inhibitors and Methods Using SameWISTAR INST·Filed 2024·Application pending·0 cites
- 2083US8450303B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 28, 2013·3 cites·17 claims
- 2182US12172974B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 2281US11306075B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Apr 19, 2022·2 cites·9 claims
- 2381US8697683B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
- 2481US8623858B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 7, 2014·2 cites·4 claims
- 2580US8691805B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 8, 2014·2 cites·8 claims
- 2677US12258314B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2021·Granted Mar 25, 2025·0 cites·7 claims
- 2776US11472776B2Quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Oct 18, 2022·1 cites·8 claims
- 2876US10421718B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2017·Granted Sep 24, 2019·1 cites·24 claims
- 2976US2025304565A1Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2025·Application pending·0 cites
- 3075US11912659B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 3172US8637498B2Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Jan 28, 2014·2 cites·30 claims
- 3271US12331043B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Granted Jun 17, 2025·0 cites·5 claims
- 3370US6313309B14-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonistsORTHO MCNEIL PHARM INC·Filed 1999·Granted Nov 6, 2001·15 cites·8 claims
- 3468US9611213B2Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathyKANNALIFE INC·Filed 2015·Granted Apr 4, 2017·2 cites·14 claims
- 3564US9856214B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2014·Granted Jan 2, 2018·0 cites·8 claims
- 3659US2024158357A1Novel quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Application pending·0 cites
- 3757US2024148722A1Small molecules that bind to tdp-43 for the treatment of als and related disordersBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 3850US2024131004A1Functionalized 1,3-benzene diols and their method of use for the treatment of inflammation and painKANNALIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 3950US2013244998A1Piperidin-4-yl-azetidine diamides as monoacylglcerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 4049US2015209379A1Treatment of prostate cancer and hematologic neoplasmsUNIV JEFFERSON·Filed 2013·Application pending·0 cites
- 4147US2025281424A1Small molecule antagonists of pf4ZHOU YUHANG·Filed 2021·Application pending·0 cites
- 4244US2022409578A1Functionalized 1,3-benzene diols and their method of use for the treatment of radiation dermatitis and other skin disordersKANNALIFE SCIENCES INC·Filed 2020·Application pending·0 cites
- 4343US10004722B2Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diolsKANNALIFE SCIENCES INC·Filed 2017·Granted Jun 26, 2018·0 cites·6 claims
- 4441US8815839B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 26, 2014·0 cites·11 claims
- 4534US7112685B2Labeled resiniferatoxin derivativesORTHO MCNEIL PHARM INC·Filed 2001·Granted Sep 26, 2006·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Mark Mcdonnell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →